Propionic acidemia: neonatal versus selective metabolic screening.

  • S C Grünert
  • S Müllerleile
  • L de Silva
  • M Barth
  • M Walter
  • K Walter
  • T Meissner
  • M Lindner
  • R Ensenauer
  • René Santer
  • O A Bodamer
  • M R Baumgartner
  • M Brunner-Krainz
  • D Karall
  • C Haase
  • I Knerr
  • T Marquardt
  • J B Hennermann
  • R Steinfeld
  • S Beblo
  • H G Koch
  • V Konstantopoulou
  • S Scholl-Bürgi
  • A van Teeffelen-Heithoff
  • T Suormala
  • W Sperl
  • J P Kraus
  • A Superti-Furga
  • K O Schwab
  • J O Sass

Related Research units

Abstract

Whereas propionic acidemia (PA) is a target disease of newborn screening (NBS) in many countries, it is not in others. Data on the benefit of NBS for PA are sparse.

Bibliographical data

Original languageEnglish
Article number1
ISSN0141-8955
Publication statusPublished - 2012
pubmed 22134541